Sign in Subscribe

approved

A collection of 3 issues

Jemperli Shows Sustained Response in dMMR/MSI-H Rectal Cancer

Skip to content The CRC Digest Jemperli Shows Sustained Response in dMMR/MSI-H Rectal Cancer Phase 2 data support potential organ preservation in patients with mismatch repair deficient tumors. (Fierce Pharma) This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026

KRAS G12C inhibitor Krazati fails confirmatory phase 3 trial

Skip to content The CRC Digest KRAS G12C inhibitor Krazati fails confirmatory phase 3 trial The Krystal-10 study did not meet primary endpoints in 461 patients with KRAS G12C-mutated metastatic colorectal cancer, raising questions about the drug's path to full FDA approval. (Fierce Pharma) This content is informational

ColoSense RNA-Based At-Home Test

Skip to content The CRC Digest ColoSense RNA-Based At-Home Test First FDA-approved RNA-based at-home screening test now available nationwide through Labcorp. This content is informational only and does not constitute medical advice. Always consult your oncologist or care team. © 2026 The CRC Digest — crcdigest.com